• Tue news: Merck's Keytruda stages comeback in head and neck cancer. GSK, Pfizer RSV vaccine sales fall. Astellas gene therapy bet. Extreme weather —>drug shortages. J&J discontinues bladder cancer drug. See more on our front page

Tomorrow Never Comes: Pfizer Says $1.5B in Savings Will Show Up … Next Year

















So this just means there are bigger reorganizations to come to me. I'd like to think a major reorg will be announced before the end of the 3rd quarter, but maybe they're waiting on Lipitor to go generic. What could they cut to see a benefit of $1B in 2012? It would have to be people because it takes Pfizer years to close down facilities.
 








Similar threads

Replies
4
Views
2K
Pfizer
anonymous
Replies
5
Views
2K
Pfizer
anonymous
Replies
30
Views
4K
Pfizer
anonymous
Replies
1
Views
1K
Pfizer
Anonymous
Replies
0
Views
973
Pfizer
Anonymous